Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degarelix Phase 2 Dose-Finding Study in Prostate Cancer
NCT00116779Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Feb 2004
- Primary completion
- Aug 2005
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of degarelix in prostate cancer (PCa), sponsored by Ferring Pharmaceuticals. Started Feb 2004; status: completed.
02
Drugs
degarelix
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00116779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00116779.